Sanofi - Aventis Groupe: Press Release: TZIELD® Phase 3

Sanofi - Aventis Groupe: Press Release: TZIELD® Phase 3 data presented at ISPAD shows potential to slow the progression of Stage 3 type 1 diabetes in newly diagnosed children and adolescents; full data simultaneously published in The NEJM

Sanofi - Aventis Groupe: Press Release: TZIELD® Phase 3 data presented at ISPAD shows potential to slow the progression of Stage 3 type 1 diabetes in newly diagnosed children and adolescents; full data simultaneously published in The NEJM

finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Related Keywords

Netherlands , Paris , France General , France , Eva Schaefer Jansen , Sandrine Guendoul , Kevan Herold , Ihre Chancen , Corentine Driancourt , Nathalie Pham , Indiens Wirtschaft , Tarik Elgoutni , Felix Lauscher , Evan Berland , Jose Eduardo Neves , Yale School Of Medicine , Nasdaq , Euronext , Global Head Of Medical Affairs , New England Journal , Long Professor , Yale School , Primary Investigator , Eduardo Neves , Vice President , Global Head , Medical Affairs , General Medicines , Provention Bio , Sanofi Company , Private Securities Litigation Reform Act , Statement Regarding Forward Looking , Der Indien , Die Highlights ,